XT
VERA icon

XTX Topco’s Vera Therapeutics VERA Stock Holding History

XTX Topco’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45M Buy
103,607
+54,994
+113% +$2.05M 0.06% 451
2026
Q1 		$1.96M Buy
48,613
+38,588
+385% +$1.66M 0.03% 853
2025
Q4 		$508K Buy
+10,025
New +$356K 0.01% 1588
2025
Q3 		– Sell
-57,919
Closed -$1.36M – 3324
2025
Q2 		$1.36M Buy
57,919
+47,423
+452% +$1.07M 0.06% 500
2025
Q1 		$252K Buy
+10,496
New +$337K 0.01% 1537
2023
Q4 		– Sell
-32,048
Closed -$439K – 2190
2023
Q3 		$439K Buy
+32,048
New +$550K 0.08% 473
2023
Q2 		– Sell
-11,815
Closed -$91.7K – 1879
2023
Q1 		$91.7K Buy
+11,815
New +$91.2K 0.02% 1109

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

XTX Topco's VERA Position: Q2 2026 in Review

XTX Topco increased its Vera Therapeutics (VERA) stake by 113% in Q2 2026, buying an estimated $2.05M and bringing the position to 103,607 shares worth $4.45M. The position accounts for 0.06% of the portfolio, ranked #451.

XTX Topco first reported a position in VERA in Q1 2023 and has held it in 7 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • XTX Topco held 103,607 shares of Vera Therapeutics worth $4.45M as of Q2 2026.
  • XTX Topco bought 54,994 Vera Therapeutics shares in Q2 2026, an estimated $2.05M.
  • Vera Therapeutics made up 0.06% of XTX Topco's portfolio in Q2 2026, its #451 holding.
  • XTX Topco first reported a position in Vera Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.